Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

被引：0
|
作者：
Xiao-yan Qiu
Zheng Jiao
Ming Zhang
Long-jin Zhong
Hui-qi Liang
Chun-lai Ma
Liang Zhang
Ming-kang Zhong
机构：
[1] Fudan University,Clinical Pharmacy Laboratory, Huashan Hospital
[2] Fudan University,School of Pharmacy
[3] Fudan University,Department of Nephrology, Huashan Hospital
来源：
European Journal of Clinical Pharmacology | 2008年 / 64卷
关键词：
MDR1; CYP3A4*18B; CYP3A5*3; Cyclosporine; Renal transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients
    Qiu, Xiao-Yan
    Jiao, Zheng
    Zhang, Ming
    Zhong, Long-Jin
    Liang, Hui-Qi
    Ma, Chun-Lai
    Zhang, Liang
    Zhong, Ming-Kang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (11) : 1069 - 1084
  • [2] ASSOCIATION OF CYP3A4*18B POLYMORPHISMS WITH THE PHARMACOKINETICS OF TACROLIMUS IN CHINESE RENAL TRANSPLANT RECIPIENTS
    Li Danying
    Fang Yun
    Teng Ruichen
    PROGRESS ON POST-GENOME TECHNOLOGIES AND MODERN NATURAL PRODUCTS, 2011, 2011, : 250 - 252
  • [3] Association of CYP3A4*18B and CYP3A5*3 polymorphism with cyclosporine-related liver injury in Chinese renal transplant recipients
    Xin, Hua-wen
    Liu, Hui-ming
    Li, Yuan-qi
    Huang, Hui
    Zhang, Li
    Yu, Ai-rong
    Wu, Xiao-chun
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (06) : 497 - 503
  • [4] Influence of ABCB1, CYP3A4*18B and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients
    Qiu, Feng
    He, Xiao-Jing
    Sun, Ya-Xin
    Li-Ling, Jesse
    Zhao, Li-Mei
    PHARMACOLOGICAL REPORTS, 2011, 63 (03) : 815 - 825
  • [5] Impact of CYP3A4*1B and CYP3A5*3 polymorphisms on the pharmacokinetics of cyclosporine and sirolimus in renal transplant recipients
    Zochowska, Dorota
    Wyzgal, Janusz
    Paczek, Leszek
    ANNALS OF TRANSPLANTATION, 2012, 17 (03) : 36 - 44
  • [6] Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation
    Hu, Yong-Fang
    Qiu, Wen
    Liu, Zhao-Qian
    Zhu, Li-Jun
    Liu, Zhong-Qi
    Tu, Jiang-Hua
    Wang, Dan
    Li, Zhi
    He, Jun
    Zhong, Gan-Ping
    Zhou, Gan
    Zhou, Hong-Hao
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (11) : 1093 - 1098
  • [7] CYP3A4*18B and CYP3A5*3 polymorphisms contribute to pharmacokinetic variability of cyclosporine among healthy Chinese subjects
    Tao, Xing-ru
    Xia, Xiu-yuan
    Zhang, Jing
    Tong, Lian-ying
    Zhang, Wei
    Zhou, Xin
    Liu, Zhi-hong
    Song, Hong-tao
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 76 : 238 - 244
  • [8] Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients
    Roy, Jean Nicholas
    Barama, Azemi
    Poirier, Charles
    Vinet, Bernard
    Roger, Michel
    PHARMACOGENETICS AND GENOMICS, 2006, 16 (09) : 659 - 665
  • [9] Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects
    Hu, Y.-F.
    Tu, J.-H.
    Tan, Z.-R.
    Liu, Z.-Q.
    Zhou, G.
    He, J.
    Wang, D.
    Zhou, H.-H.
    XENOBIOTICA, 2007, 37 (03) : 315 - 327
  • [10] Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients
    Shi, Yunying
    Li, Yi
    Tang, Jiangtao
    Zhang, Junlong
    Zou, Yuangao
    Cai, Bei
    Wang, Lanlan
    GENE, 2013, 512 (02) : 226 - 231
12345